Tvardi Therapeutics, Inc. (TVRD)

CIK 1346830 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tvardi Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001104659-26-096424
Aug 14, 20268-K0001104659-26-096417
Jul 30, 20268-K0001104659-26-088461
Jul 17, 20268-K0001104659-26-084627
Jul 17, 2026424B50001104659-26-084619
Jul 7, 20268-K0001104659-26-080930
Jun 11, 20268-K0001104659-26-072930
Jun 11, 202640001201256-26-000003
Jun 11, 202640001609480-26-000002
Jun 11, 202640001811463-26-000002
Jun 11, 202640001588861-26-000002
Jun 11, 202640001762801-26-000002
May 13, 2026EFFECT9999999995-26-001601
May 12, 2026EFFECT9999999995-26-001593
May 8, 20268-K0001104659-26-057524
May 8, 2026POS AM0001104659-26-057914
May 8, 202610-Q0001104659-26-057528
May 1, 2026S-30001104659-26-054113
Apr 23, 2026DEFA14A0001104659-26-047700
Apr 23, 2026DEF 14A0001104659-26-047695
Apr 23, 2026ARS0001104659-26-047713
Apr 1, 2026POS EX0001104659-26-038128
Apr 1, 2026S-80001104659-26-038133
Apr 1, 2026424B30001104659-26-038109
Mar 31, 20268-K0001104659-26-037724